NDA Insights

Stay updated with the latest information
on drug development. 
You can also sign up to our newsletter to
make sure you don't miss anything.

NDA News & Events
Date Title Author

Making Sense of INDs – Your Key to Clinical Trials

The Investigational New Drug (IND) application is a critical milestone in bringing new biomedical treatments to patients in the US.
Read more
28-11-2023

Get to know our experts – Jan Sjöberg

In this article, we shine the spotlight on Dr Jan Sjöberg, Medical Advisor and NDA Advisory Board Member
Read more
23-11-2023

Paediatric Development: Your Roadmap to MHRA Compliance

A Paediatric Investigation Plan (PIP) is a key regulatory requirement of the MHRA. It provides a framework for evaluating investigational drugs to assess their quality, safety and efficacy in children.
Read more
15-11-2023

Prescribing for the Future: How the EU PIP Guidelines Support Children’s Health

The Paediatric Investigation Plan (PIP) is a tool designed to guide the collection of necessary data through paediatric studies, and if necessary, quality, and nonclinical studies.
Read more
31-10-2023

Navigating Policy Shifts in Europe with Dr Thomas Lönngren

The first episode of our video series features Dr Laurie Smaldone Alsup in a thoughtful dialogue with Dr Thomas Lönngren regarding opportunities and developments in European healthcare regulation.
Read more
25-10-2023

Get to know our experts – Tatiana Reimer

In this article, we shine the spotlight on Dr Tatiana Reimer, Principal Consultant at NDA.
Read more
24-10-2023
Load more

Contact us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.

This website uses cookies

Cookies ("cookies") consist of small text files. The text files contain data which is stored on your device. To be able to place some type of cookies we need your consent. We at NDA Group AB, corporate identity number 556654-3046 use these types of cookies. To read more about which cookies we use and storage duration, click here to get to our cookiepolicy.

Manage your cookie-settings

Necessary cookies

Necessary cookies are cookies that need to be placed for fundamental functions on the website to work. Fundamental functions are for instance cookies that are needed for you to use menus and navigate the website.

Statistical cookies

To know how you interact with the website we place cookies to collect statistics. These cookies anonymize personal data.

Ad measurement cookies

To be able to provide a better service and experience we place cookies to tailor marketing for you. Another purpose for this placement is to market products or services to you, give tailored offers or market and give recommendations on new concepts based on what you have bought from us previously.
Confirm choices Accept all